Evidence map›Paper›PMID 40305354›Full record

ArticleEmerging infectious diseases2025

Postexposure Antimicrobial Drug Therapy in Goats Infected with Burkholderia pseudomallei.

Richard A Bowen, Airn E Hartwig, Angela M Bosco-Lauth, Josilene N Seixas, Jana M Ritter, Pamela S Fair, Mindy G Elrod, Zachary P Weiner, Robyn A Stoddard, Antonio R Vieira and 5 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Richard A Bowen
Airn E Hartwig
Angela M Bosco-Lauth
Josilene N Seixas
Jana M Ritter
Pamela S Fair
Mindy G Elrod
Zachary P Weiner
Robyn A Stoddard
Antonio R Vieira
Rachel M Maison
Elizabeth Lawrence
Hannah Sueper
Mckinzee Barker
William A Bower

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection with Burkholderia pseudomallei, the causative agent of melioidosis, occurs by exposure to the organism in soil or water. There is concern for B. pseudomallei use as a potential bioweapon and as an exposure hazard in diagnostic laboratories processing samples or cultures containing the bacterium. The optimal strategies for treatment and postexposure prophylaxis are inadequately developed. This study used goats to evaluate 3 antimicrobial drug treatment regimens for postexposure therapy because they are a species naturally susceptible to B. pseudomallei infection. Goats were infected by percutaneous inoculation, and antimicrobial drug therapies were initiated 48 hours later. Widespread infection with abscess formation in multiple organs developed in untreated goats and goats treated with either amoxicillin/clavulanate or sulfamethoxazole/trimethoprim. In contrast, treatment with the combination of all 4 antimicrobial drugs might have eradicated the infection. Our findings suggest combination therapy with those 4 antimicrobial drugs may be useful for postexposure prophylaxis in humans.

Indexed as

Anti-Bacterial AgentsBurkholderia pseudomalleiGoat DiseasesMelioidosisPost-Exposure ProphylaxisAnimalsDrug Therapy, CombinationGoatsTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsTrimethoprim, Sulfamethoxazole Drug Combinationantimicrobial resistancebacteriaBurkholderia pseudomalleigoatsMelioidosispostexposure prophylaxisprophylaxis

Identifiers

PMID40305354
PMCPMC12044257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.